Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2/3 1

Status

Unknown 2Recruiting 2Completed 2Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Leukemia, Myeloid, Acute 22Leukemia 14Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Leukemia, Monocytic, Acute 5Myelodysplastic Syndromes 4Leukemia, Promyelocytic, Acute 4Leukemia, Myelomonocytic, Acute 4Leukemia, Megakaryoblastic, Acute 4Leukemia, Erythroblastic, Acute 4Multiple Myeloma 3Lymphoma 3Neoplasms, Plasma Cell 2Lymphoma, Follicular 2Lymphoma, B-Cell, Marginal Zone 2Leukemia, T-Cell 2Leukemia, Myeloid, Chronic-Phase 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Leukemia, Lymphocytic, Chronic, B-Cell 2Carcinoma, Hepatocellular 2Anemia, Refractory, with Excess of Blasts 2Recurrence 1Philadelphia Chromosome 1Neutropenia 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1

Interventions

Sorafenib 46lenvatinib 44apatinib 23sintilimab 22Fluorouracil 21camrelizumab 20Oxaliplatin 17Radiofrequency Ablation 16Radiosurgery 15Hepatectomy 15tislelizumab 14Leucovorin 14Radiotherapy 12Doxorubicin 12toripalimab 11Folfox protocol 10Bevacizumab 10Immune Checkpoint Inhibitors 9Epirubicin 9regorafenib 8Ethiodized Oil 8durvalumab 7donafenib 7anlotinib 7Neoadjuvant Therapy 7pembrolizumab 6entecavir 6Surgical Procedures, Operative 6Nivolumab 6Injections 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Carcinoma, Hepatocellular × Idarubicin × Clear all
NCT05280444 2022-12-29

Lipiodol-TACE With Idarubicin for Hepatocellular Carcinoma

Zhongda Hospital

Phase 2/3 Unknown
216 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT05053386 2021-09-22

Idarubicin vs. Epirubicin TACE in the Treatment of Hepatocellular Carcinoma

Zhejiang Cancer Hospital

Phase NA Unknown
186 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡